Suneel Gupta - Net Worth and Insider Trading
Suneel Gupta Net Worth
The estimated net worth of Suneel Gupta is at least $11 Million dollars as of 2024-12-27. Suneel Gupta is the Chief Development Officer of Protagonist Therapeutics Inc and owns about 267,433 shares of Protagonist Therapeutics Inc (PTGX) stock worth over $11 Million. Details can be seen in Suneel Gupta's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Suneel Gupta has not made any transactions after 2024-11-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Suneel Gupta
Suneel Gupta Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Suneel Gupta owns 1 companies in total, including Protagonist Therapeutics Inc (PTGX) .
Click here to see the complete history of Suneel Gupta’s form 4 insider trades.
Insider Ownership Summary of Suneel Gupta
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc | 2024-11-26 | Chief Development Officer |
Suneel Gupta Latest Holdings Summary
Suneel Gupta currently owns a total of 1 stock. Suneel Gupta owns 267,433 shares of Protagonist Therapeutics Inc (PTGX) as of November 26, 2024, with a value of $11 Million.
Latest Holdings of Suneel Gupta
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc | 2024-11-26 | 267,433 | 39.51 | 10,566,278 |
Holding Weightings of Suneel Gupta
Suneel Gupta Form 4 Trading Tracker
According to the SEC Form 4 filings, Suneel Gupta has made a total of 2 transactions in Protagonist Therapeutics Inc (PTGX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Protagonist Therapeutics Inc is the sale of 122,628 shares on November 26, 2024, which brought Suneel Gupta around $6 Million.
Insider Trading History of Suneel Gupta
- 1
Suneel Gupta Trading Performance
GuruFocus tracks the stock performance after each of Suneel Gupta's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Suneel Gupta is 70.15%. GuruFocus also compares Suneel Gupta's trading performance to market benchmark return within the same time period. The performance of stocks bought by Suneel Gupta within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Suneel Gupta's insider trading performs compared to the benchmark.
Performance of Suneel Gupta
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 40.51 | | | | | |
| Relative Return to S&P 500(%) | 35.93 | | | | | |
Suneel Gupta Ownership Network
Suneel Gupta Owned Company Details
What does Protagonist Therapeutics Inc do?
Who are the key executives at Protagonist Therapeutics Inc?
Suneel Gupta is the Chief Development Officer of Protagonist Therapeutics Inc. Other key executives at Protagonist Therapeutics Inc include Chief Medical Officer Arturo Md Molina , director & President and CEO Patel Dinesh V Ph D , and Chief Financial Officer Asif Ali .
Protagonist Therapeutics Inc (PTGX) Insider Trades Summary
Over the past 18 months, Suneel Gupta made 2 insider transaction in Protagonist Therapeutics Inc (PTGX) with a net sale of 127,628. Other recent insider transactions involving Protagonist Therapeutics Inc (PTGX) include a net sale of 265,000 shares made by Patel Dinesh V Ph D , a net sale of 36,975 shares made by William D. Waddill , and a net sale of 39,624 shares made by Asif Ali .
In summary, during the past 3 months, insiders sold 256,063 shares of Protagonist Therapeutics Inc (PTGX) in total and bought 0 shares, with a net sale of 256,063 shares. During the past 18 months, 504,510 shares of Protagonist Therapeutics Inc (PTGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 504,510 shares.
Protagonist Therapeutics Inc (PTGX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protagonist Therapeutics Inc Insider Transactions
Suneel Gupta Mailing Address
Above is the net worth, insider trading, and ownership report for Suneel Gupta. You might contact Suneel Gupta via mailing address: 7707 Gateway Blvd., Suite 140, Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
